This test is most useful if any of these apply to you.
Calcium oxalate stones are one of the most painful conditions you can experience, and most prevention advice focuses on what you drink and what you eat. There is another player most people never think about: a specific bacterium living in your gut that literally eats oxalate for a living.
When this bacterium is present, research links it to roughly 70% lower odds of recurrent calcium oxalate kidney stones. When it is absent, often because antibiotics wiped it out years earlier, your body has one fewer defense against oxalate accumulating in your urine and crystallizing into stones.
Oxalobacter formigenes (OF for short) is a normal resident of the large intestine that uses oxalate as its only source of carbon and energy. It takes oxalate from the food you eat and from the oxalate your own body produces, then breaks it down into harmless byproducts before it can be absorbed into your bloodstream and filtered out through your kidneys.
The less oxalate that makes it into your urine, the less raw material there is to form calcium oxalate crystals. That is the central reason researchers have spent four decades studying this one bacterium. It is also one of the few gut microbes where the connection between its presence and a specific human disease has been demonstrated in controlled feeding studies, not just association data.
The most striking finding about OF comes from a case-control study of recurrent stone formers. People colonized with this bacterium had about 70% lower odds of being a recurrent calcium oxalate stone former compared to people without it. Smaller studies in stone formers consistently show that colonized individuals have fewer prior stone episodes and lower urinary oxalate than those without the bacterium.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Adults with a history of calcium oxalate stones (506 people) | Colonized vs not colonized | About 70% lower odds of being a recurrent stone former if colonized |
| Healthy adults on a controlled low-calcium, moderate-oxalate diet (22 people) | Colonized vs not colonized | Roughly 19 to 20% lower urinary oxalate if colonized |
| Healthy adults given a single oral dose of live Oxalobacter (22 people) | Before vs after colonization | Average 14% drop in urinary oxalate after colonization took hold |
Sources: Kaufman et al. 2008; Jiang et al. 2011; Fargue et al. 2025. What this means for you: if you have had even one calcium oxalate stone, whether this bacterium is living in your gut is one of the few modifiable factors that has been directly tied to your risk of forming another.
Hyperoxaluria is the medical term for having too much oxalate in your urine. It can happen because your body absorbs more oxalate than usual, because you eat more, or because a gut condition disrupts fat absorption and causes oxalate to be absorbed in places it normally would not. OF colonization is linked to lower urinary oxalate in each of these situations.
In children with cystic fibrosis, the bacterium is almost entirely absent, and its absence strongly correlates with hyperoxaluria. In children with Crohn's disease, lack of OF colonization is one of the main risk factors for enteric hyperoxaluria. In inflammatory bowel disease more broadly, colonization is rare, and patients tend to have higher urinary oxalate.
In primary hyperoxaluria, a rare genetic condition where the liver produces excessive oxalate, oral OF has been tested as a therapy. Late-phase trials showed trends toward lower plasma oxalate and stabilization, though results have been mixed and not always statistically significant.
Colonization with OF is present in only about 30 to 40% of healthy US adults. In remote indigenous populations, prevalence runs 60 to 80%. The gap is almost certainly driven by modern antibiotic use. Several common antibiotic classes, including macrolides, tetracyclines, chloramphenicol, and sulfa drugs, suppress the bacterium, and the effect can last for years after a single course.
In one population study, 55% of adults who had not taken sensitive antibiotics were colonized, compared to 17 to 36% of those who had. This is one plausible reason why kidney stone incidence has climbed alongside antibiotic use in developed countries.
This is an exploratory marker without universally agreed clinical cutpoints. No guideline body publishes reference ranges, and different labs use different detection methods (PCR, whole-genome sequencing, culture) that are not directly comparable. The research-derived ranges below come from population studies of healthy adults and stool colonization quantification, not from a standardized clinical assay.
| Status | What It Suggests | Typical Finding |
|---|---|---|
| Detected (colonized) | Active oxalate-degrading capacity in your gut | Found in about 30 to 40% of US adults; 60 to 80% of remote indigenous populations |
| Not detected | Either truly absent or below the method's detection threshold | Common after recent antibiotic exposure; more common in stone formers, IBD, and cystic fibrosis |
| Quantified abundance | Levels can vary within the same person between stool samples | Ranges from under 5,000 to over one billion cells per gram of stool in colonized adults |
Sources: Barnett et al. 2016; Pebenito et al. 2019; Prokopovich et al. 2007. Compare your results within the same lab over time for the most meaningful trend, since methods and detection thresholds differ significantly between labs.
A few situations can distort a single reading and lead you to the wrong conclusion:
Because OF levels vary between stool samples in the same person, a single test should not be treated as definitive. If you are actively trying to recolonize after antibiotics, or monitoring whether a lifestyle change is affecting your gut, retesting gives you a much better picture than any one reading.
A practical approach: get a baseline now to see where you stand. If the result is negative or low and you are making changes (dietary, probiotic, or post-antibiotic recovery), retest in 3 to 6 months. After that, annual testing is reasonable if you are actively managing kidney stone risk or have a condition like IBD or cystic fibrosis. The trend over several samples is far more informative than a single number.
A negative OF result on its own does not mean you are destined to form stones. It becomes actionable when combined with other evidence of oxalate risk. If you test negative, consider pairing this result with a 24-hour urine collection that measures oxalate, calcium, citrate, uric acid, and volume. That panel tells you whether your urine chemistry is actually showing elevated lithogenic risk right now.
If your urinary oxalate is high and OF is absent, that pattern is worth discussing with a urologist or nephrologist, particularly if you have had a stone, have IBD, have had bariatric surgery, or have cystic fibrosis. If you have had kidney stones and want a complete workup, a stone-forming specialist can help you interpret OF alongside other factors (dietary analysis, family history, imaging, and full metabolic stone panel) to build a targeted prevention plan.
One important caveat: this is still an emerging marker. Even colonized individuals form stones, and many uncolonized people never do. Treat the result as one piece of a larger risk picture, not a verdict.
Evidence-backed interventions that affect your Oxalobacter Formigenes level
Oxalobacter Formigenes is best interpreted alongside these tests.